Review Article| Volume 36, ISSUE 4, P685-692, December 2016

Toxicology in Addiction Medicine


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dupont R.L.
        Drug Testing: a white paper of the American Society of Addiction Medicine.
        ASAM, Chevy Chase (MD)2013: 5-108
        • Kirsh K.L.
        • Baxter L.E.
        • Rzetelny A.
        • et al.
        A survey of ASAM members' knowledge, attitudes, and practices in urine drug testing.
        J Addict Med. 2015; 9: 399-404
        • Tenore P.L.
        Advanced urine toxicology testing.
        J Addict Dis. 2010; 29: 436-448
        • Cone E.J.
        • DePriest A.Z.
        • Heltsley R.
        • et al.
        Prescription opioids. IV: disposition of hydrocodone in oral fluid and blood following single-dose administration.
        J Anal Toxicol. 2015; 39: 510-518
        • Mee-Lee D.
        • American Society of Addiction Medicine
        The ASAM criteria: treatment for addictive, substance-related, and co-occurring conditions.
        3rd edition. American Society of Addiction Medicine, Chevy Chase (MD)2013: xv (460)
      1. Washington State Agency Medical Directors' Group. Interagency guideline on prescribing opioids for pain. 3rd edition. 2015.

      2. Ohio Department of Health. 2014 Ohio Drug Overdose Data: General Findings; 2016. p. 1–10.

      3. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Drug-Poisoning Death Involving Opioid Analgesics. NCHS Data Brief, No.166, September 2014.

        • Saitman A.
        • Park H.D.
        • Fitzgerald R.L.
        False-positive interferences of common urine drug screen immunoassays: a review.
        J Anal Toxicol. 2014; 38: 387-396
        • Manchikani L.
        • Malla Y.
        • Wargo B.W.
        • et al.
        Protocol for accuracy of point of care (POC) or in-iffice unrine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectrometry (LC/MS/MS).
        Pain Physician. 2010; 13: E1-E22
        • Kirsh K.L.
        • Christo P.J.
        • Heit H.
        • et al.
        Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications.
        J Opioid Manag. 2015; 11: 53-59
        • Reisfield G.M.
        • Goldberger B.A.
        • Bertholf R.L.
        'False-positive' and 'false-negative' test results in clinical urine drug testing.
        Bioanalysis. 2009; 1: 937-952
        • Starrels J.L.
        • Fox A.D.
        • Kunins H.V.
        • et al.
        They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.
        J Gen Intern Med. 2012; 27: 1521-1527
        • Markway C.E.
        • Baker S.N.
        A review of the methods, interpretation, and limitations of the urine drug screen.
        Orthopedics. 2011; 34: 877-881
        • Reisfield G.M.
        • Bertholf R.
        • Barkin R.L.
        • et al.
        Urine drug test interpretation: what do physicians know?.
        J Opioid Manag. 2007; 3: 80-86
      4. Centers for Medicare and Medicaid, Calendar Year (CY) 2016 Clinical Laboratory Fee Schedule (CLFS), Final Determination, November 2015.

        • Yuan C.
        • Heideloff C.
        • Kozak M.
        • et al.
        Simultaneous quantification of 19 drugs/metabolites in urine important for pain management by liquid chromatography-tandem mass spectrometry.
        Clin Chem Lab Med. 2012; 50: 95-103
        • Yuan C.
        • Lembright K.
        • Heideloff C.
        • et al.
        Quantification of buprenorphine, norbuprenorphine and 6-monoacetylmorphine in urine by liquid chromatography-tandem mass spectrometry.
        J Chrom Separ Tech. 2013; 4: 174
        • Kosten T.R.
        • Wu G.
        • Huang W.
        • et al.
        Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase.
        Biol Psychiatry. 2013; 73: 219-224
        • Schifano F.
        Misuse and abuse of pregabalin and gabapentin: cause for concern?.
        CNS Drugs. 2014; 28: 491-496
        • Furr-Holden C.D.
        • Milam A.J.
        • Nesoff E.D.
        • et al.
        Not in my back yard: a comparative analysis of crime around publicly funded drug treatment centers, liquor stores, convenience stores, and corner stores in one mid-Atlantic city.
        J Stud Alcohol Drugs. 2016; 77: 17-24
        • Helander A.
        • Böttcher M.
        • Fehr C.
        • et al.
        Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification.
        Alcohol Alcohol. 2009; 44: 55-61
        • Reisfield G.M.
        • Goldberger B.A.
        • Pesce A.J.
        • et al.
        Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash.
        J Anal Toxicol. 2011; 35: 264-268
        • Costantino A.
        • Digregorio E.J.
        • Korn W.
        • et al.
        The effect of the use of mouthwash on ethylglucuronide concentrations in urine.
        J Anal Toxicol. 2006; 30: 659-662
        • Marinetti L.J.
        • Ehlers B.J.
        A series of forensic toxicology and drug seizure cases involving illicit fentanyl alone and in combination with heroin, cocaine or heroin and cocaine.
        J Anal Toxicol. 2014; 38: 592-598
        • Cone E.J.
        • Heltsley R.
        • Black D.L.
        • et al.
        Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration.
        J Anal Toxicol. 2013; 37: 486-494
        • Moeller K.E.
        • Lee K.C.
        • Kissack J.C.
        Urine drug screening: practical guide for clinicians.
        Mayo Clin Proc. 2008; 83: 66-76
        • Dowell D.
        • Haegerich T.M.
        • Chou R.
        CDC guideline for prescribing opioids for chronic pain—United States, 2016.
        MMWR Recomm Rep. 2016; 65: 1-49
        • Ward M.B.
        • Hackenmueller S.A.
        • Strathmann F.G.
        • Education Committee of the Academy of Clinical Laboratory Physicians and Scientists
        Pathology consultation on urine compliance testing and drug abuse screening.
        Am J Clin Pathol. 2014; 142: 586-593